Pakiet Ochrony przed STD
✅ Reduces STD infection risk
✅ Protects against HIV
✅ Leczenie infekcji bakteryjnych
✅ Prevents recurrent STDs
✅ Wspiera zdrowie seksualne
Pakiet Ochrony przed STD zawiera PrEP (Emtricitabine and Tenofovir), Doxycycline & Azithromycin.
✓ Zweryfikowany medycznie przez Morgan Ellis — Badacz farmaceutyczny · 8 lat doświadczenia · Ostatnia weryfikacja: maj 2026
⚡ Quick Answer — What is the STD Protection Pack?
The Pakiet Ochrony przed STD bundles three prescription medications used together for sexual-health prevention and treatment: TDF/FTC 30 tablets (HIV pre-exposure prophylaxis), doxycycline 100 mg 60 capsules (bacterial-STI post-exposure prophylaxis and chlamydia/syphilis treatment), and azithromycin 250 mg 18 tablets (gonorrhoea or chlamydia treatment course). This is a prescription stack requiring baseline HIV testing, clinician oversight, and quarterly STI screening.
📦 Każde zamówienie jest objęte naszą Reshipment Assurance Policy — jeśli Twoja przesyłka nie dotrze w ciągu 20 dni roboczych, wysyłamy ją ponownie.
Dlaczego warto zamawiać z MedsBase
Zamawiając z MedsBase, otrzymujesz produkty od producenta certyfikowanego przez WHO-GMP, dyskretne opakowanie w zwykłej kopercie, wysyłkę na całym świecie i ocenę 4.9★ od ponad 1400 zweryfikowanych klientów. Płatności kartą są przetwarzane przez regulowanego dostawcę usług płatniczych — na wyciągu bankowym widnieje nazwa procesora (regulowanego dostawcy płatności kartowych), a nigdy “MedsBase” lub nazwa leku. Każda przesyłka objęta jest naszą Reshipment Assurance Policy.
Pakiet Ochrony przed STD is a curated 3-medication bundle designed around a modern sexual-health strategy: continuous HIV prophylaxis (via daily TDF/FTC) combined with bacterial-STI prevention and treatment (via doxycycline) and a course of azithromycin for specific bacterial infections when indicated. It is targeted primarily at sexually active men who have sex with men (MSM), transgender women, and others at substantial STI risk who want one prescription bundle covering the most common sexual-transmission pathogens.
This bundle requires careful clinical oversight. It is not a single product with one indication — it is a clinical stack. Each component has its own dosing, its own monitoring requirements, and its own contraindications. Please read the individual sections below before using.
What Is in the Pack?
| Component | Ilość | Purpose |
|---|---|---|
| Tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg (TDF/FTC) | 30 tablets (1 month daily dosing) | HIV pre-exposure prophylaxis (PrEP) — daily HIV prevention |
| Doxycycline 100 mg | 60 capsules | Treatment of chlamydia, syphilis, and some gonorrhoea cases. Also used as DoxyPEP — post-exposure prophylaxis for bacterial STIs, CDC-recommended for MSM and transgender women (2024 guidelines) |
| Azithromycin 250 mg | 18 tablets | Treatment course for gonorrhoea (with ceftriaxone) or alternative for chlamydia where doxycycline is contraindicated. Not recommended as PEP due to rising macrolide resistance |
Component 1 — TDF/FTC for HIV Prevention (PrEP)
The TDF/FTC tablets in this pack are used for codzienna profilaktyka przedekspozycyjna HIV (PrEP). When taken consistently, daily TDF/FTC reduces HIV-1 infection risk by over 99% (iPrEx, PROUD, Partners PrEP). The component here is identical to Tenvir EM.
Mandatory baseline tests before starting PrEP:
- HIV test — must be confirmed negative (otherwise TDF/FTC is sub-therapeutic for active HIV and selects for resistance)
- Hepatitis B (HBsAg) — TDF treats HBV; stopping in HBV-positive patients can trigger hepatitis flare
- Renal function (eGFR) — TDF is renally cleared; eGFR <60 mL/min is a contraindication to TDF-based PrEP
- Baseline STI screen
Ongoing monitoring: HIV test every 3 months, renal function every 6 months, STI screen every 3 months.
For the full PrEP protocol, dosing options (daily vs on-demand 2-1-1), side effects, contraindications, and discontinuation guidance, see the kompletna strona Tenvir EM.
Component 2 — Doxycycline 100 mg
Doxycycline serves two roles in this pack:
Role A — Treatment of bacterial STIs
- Chlamydia trachomatis: 100 mg twice daily for 7 days. CDC 2021 first-line (replaced azithromycin as first-line due to efficacy and reduced Mycoplasma genitalium selection pressure)
- Syphilis (early/secondary): 100 mg twice daily for 14 days if penicillin is contraindicated
- Non-gonococcal urethritis: 100 mg twice daily for 7 days
Role B — DoxyPEP (post-exposure prophylaxis for bacterial STIs)
DoxyPEP is the use of a single 200 mg dose of doxycycline within 72 hours of a high-risk sexual exposure to prevent bacterial STIs. Evidence from the San Francisco DoxyPEP trial (2022) and Molina et al. (2018) showed approximately 65% reduction in chlamydia, syphilis, and gonorrhoea incidence in MSM and transgender women taking DoxyPEP. The CDC formally endorsed DoxyPEP for MSM and transgender women in 2024.
DoxyPEP dosing: 200 mg orally as a single dose within 72 hours (ideally within 24 hours) of condomless sex. Do not exceed 200 mg per 24-hour period. DoxyPEP is not recommended for cisgender women — trial evidence showed mixed results in this population.
Doxycycline common side effects: GI upset, photosensitivity (wear sunscreen, avoid tanning beds), oesophageal irritation (take with a full glass of water, stay upright for 30 minutes). Contraindicated in pregnancy, breastfeeding, and children under 8 due to tooth staining and bone growth effects.
Component 3 — Azithromycin 250 mg
The azithromycin in this pack is provided as a treatment-course supply — not as routine PEP. Appropriate uses:
- Gonorrhoea (urethral/rectal/pharyngeal): as part of a dual regimen with ceftriaxone IM, per CDC 2021 guidelines. Azithromycin alone is inadequate for gonorrhoea due to macrolide resistance
- Chlamydia (alternative) where doxycycline is contraindicated (pregnancy, allergy): 1 g single dose. Doxycycline is preferred first-line per CDC 2021
- Mycoplasma genitalium (some strains): 1 g day 1, then 500 mg days 2–5, typically with a macrolide-susceptibility assay
Azithromycin is NOT appropriate for DoxyPEP — the CDC explicitly recommends doxycycline over azithromycin for PEP due to rising macrolide resistance and narrower efficacy spectrum.
Common side effects: nausea, diarrhoea, abdominal pain, QT prolongation (caution with other QT-prolonging drugs, especially methadone and certain antipsychotics).
Who Is This Pack For?
- Sexually active cisgender MSM and transgender women with multiple partners or inconsistent condom use
- People starting PrEP who also want on-hand DoxyPEP coverage and a course of azithromycin for specific treatment situations
- HIV-negative adults who have confirmed baseline testing (HIV, HBV, renal, STI screen) and clinician access for ongoing quarterly monitoring
Who This Pack Is NOT For
- HIV-positive individuals — TDF/FTC alone is inadequate HIV treatment and causes resistance. See Leki na HIV for appropriate regimens
- Kobiet w ciąży lub karmiących piersią — doxycycline is contraindicated
- Children under 8 — doxycycline is contraindicated due to tooth staining
- People with eGFR <60 mL/min — TDF is contraindicated; consider TAF-based alternatives
- Cisgender women seeking DoxyPEP — current trial evidence does not support DoxyPEP in cis-women; daily PrEP remains standard
- Anyone with a macrolide allergy or QT-prolonging condition where azithromycin is unsafe
Przechowywanie
- Store each component in its original packaging
- Below 30°C, cool and dry; doxycycline capsules are particularly heat-sensitive
- Do not use after the expiry date on any component
- Przechowywać w miejscu niedostępnym dla dzieci i zwierząt
Related Pages
- Tenvir EM — comprehensive page on TDF/FTC PrEP (same active ingredient as this pack’s HIV component)
- Tenvir AF — TAF-based PrEP alternative (gentler on kidneys and bones)
- Kapsułki Doksycyklina — dedicated page for the antibiotic in this pack
- Sexual Health category
- HIV Medication category
Najczęściej zadawane pytania
Is the STD Protection Pack a single drug?
No. It is a 3-medication bundle combining TDF/FTC (for HIV PrEP), doxycycline (for DoxyPEP and bacterial STI treatment), and azithromycin (for specific bacterial STI treatment courses). Each component has its own dosing and monitoring requirements.
Does this pack replace condoms?
Nie. Condoms are the only measure that protects against all sexually transmitted infections simultaneously. PrEP prevents HIV only; DoxyPEP reduces bacterial STI risk but does not eliminate it; neither prevents genital herpes, HPV, or mpox. Use condoms alongside this pack for comprehensive protection.
Do I need to see a doctor before using it?
Tak. The TDF/FTC component requires confirmed HIV-negative status, baseline HBV/renal/STI testing, and ongoing quarterly HIV and STI monitoring. Doxycycline and azithromycin also have contraindications that require clinician review (pregnancy, allergy, drug interactions).
What is DoxyPEP and is it in this pack?
DoxyPEP is the use of a single 200 mg doxycycline dose within 72 hours of a high-risk sexual exposure to reduce bacterial STI risk. Evidence shows ~65% reduction in chlamydia, syphilis, and gonorrhoea incidence in MSM and transgender women. The doxycycline 100 mg capsules in this pack can be used for DoxyPEP (take 2 capsules = 200 mg within 72 hours of exposure).
How often should I get tested while using this pack?
HIV: every 3 months. Full STI screen (chlamydia, gonorrhoea, syphilis): every 3 months. Renal function and hepatitis: every 6 months. This is the standard PrEP monitoring cadence and applies to everyone using TDF/FTC prophylactically.
Is DoxyPEP safe for cisgender women?
Current trial evidence does not support DoxyPEP for cisgender women — the dPEP trial in Kenyan women did not show the same reduction as the MSM trials. CDC 2024 guidelines recommend DoxyPEP specifically for MSM and transgender women. Cis-women should discuss alternatives with their clinician.
Can I take all three medications at the same time?
They are taken on different schedules. PrEP is daily; DoxyPEP is episodic (within 72 hours of exposure, max once per 24 hours); the azithromycin course is prescription-directed for a specific diagnosed infection. They do not typically interact, but disclose all three to your clinician for review.
What are the main side effects to watch for?
TDF/FTC: first-week nausea/headache, long-term renal and bone monitoring needs. Doxycycline: GI upset, photosensitivity, oesophageal irritation — take with water and stay upright. Azithromycin: GI upset, rarely QT prolongation. Seek urgent medical attention for severe fatigue, jaundice, unexplained muscle pain, or irregular heartbeats.
Is this pack cheaper than buying the components separately?
The pack is a bundle SKU meant to offer a convenient 1-month starter supply for the most common sexual-health-prevention strategy. For price comparison with individual items, see the linked pages above.
If your STD-prevention strategy includes ongoing HIV PrEP plus on-demand bacterial-STI cover, our Pakiet Startowy PrEP (Tenvir-EM + doksycyklina 100 mg) bundles daily TDF/FTC with doxy-PEP doxycycline in matched 1, 3, or 6-month tiers — different scope from the broader STD Protection Pack.
Other Sexual-Health and Anti-Infective Medications
- Tenvir EM (TDF/FTC) — daily HIV PrEP backbone
- Doxt (Doxycycline) — STI post-exposure prophylaxis & chlamydia / syphilis treatment
- Azee (Azithromycin) — gonorrhoea / chlamydia regimens
- Cifran (Ciprofloxacin) — adjunct fluoroquinolone
- Metrogyl (Metronidazole) — anaerobic / protozoal cover
Więcej opcji w leczeniu chlamydiozy
Ranking według liczby ostatnich zamówień MedsBase — co wybierają inni klienci w tej kategorii.
| Ilość | 1 Pack, 2 Packs, 3 Packs, 6 Packs |
|---|
Pakiet Ochrony przed STD
Pytania i odpowiedzi
Pakiet Ochrony przed STD
Produkty powiązane
Opinie
Nie ma jeszcze opinii